First, previous studies showed that glucosamine may increase fasting blood glucose, accelerate atherosclerosis, and reduce insulin sensitivity [6,7,8,9,32,33,34,35,36,37], which have been widely identified as risk factors for cardiovascular diseases [38,39,40,41]. This evidence concerns the gene INS and atherosclerosis.